This is a $12,794.40 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract is for the delivery of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of August 28, 2024 and does not have a set-aside designation. Boston Scientific is an experienced federal contractor, having received numerous contracts and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The $21,316.72 fixed-price contract is for the Eluvia Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of December 12, 2024. Boston Scientific is the prime contractor and sole provider for this award, which is not associated with a set-aside program. The contract builds on Boston...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading medical device manufacturer, for the supply of the ELUVIA Drug Eluting Stent. The contract has a ceiling value of $8,464.00 and an ultimate completion date of September 12, 2024. The contract is a fixed-price with economic price adjustment and is not set aside. Boston Scientific, doing business as Boston Scientific, is the prime contractor and the manufacturer of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, doing business as Boston Scientific, for the supply of Eluvia Drug Eluting Stents. The contract has a ceiling value of $19,894.22 and an ultimate completion date of September 27, 2024. It is not set aside for any specific socioeconomic program. Boston Scientific is a leading manufacturer of medical devices that provides innovative, minimally invasive solutions to federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company. The contract is for the procurement of Eluvia Drug Eluting Stents, which are specialized cardiovascular devices. The contract has a ceiling value of $107,249.09 and a performance period through January 30, 2025. This award does not utilize any set-aside designations. Boston Scientific, as the prime contractor, will be responsible for providing the...
This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Logistics Agency (DLA), a Defense agency, for the supply of the ELUVIA Drug Eluting Stent. The contract has a total ceiling value of $4,655.20 and is a fixed-price delivery order with an economic price adjustment. The contract has no set-aside designation and will be performed in Marlborough, Massachusetts. Boston Scientific is the prime contractor, and the contract award date is...
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Boston Scientific Corporation, doing business as Boston Scientific, a leading manufacturer of medical devices. The contract, with a ceiling value of $12,241.35, is for the delivery of Eluvia Drug Eluting Stents, a specialized cardiovascular medical device. The contract has a fixed-price with economic price adjustment pricing type and a completion date of July 17, 2024. Boston Scientific is the prime...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Boston Scientific Corporation for the supply of ELUVIA Drug Eluting Stents. The fixed-price contract has a ceiling value of $4,787.60 and an ultimate completion date of August 20, 2024. It was awarded on August 13, 2024 and does not have a set-aside designation. Boston Scientific Corporation is a leading medical device manufacturer that provides a wide range of innovative,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation for the procurement of the Eluvia Drug Eluting Stent, a medical device. The contract has a total ceiling value of $8,464.00 and is set to expire on September 19, 2024. The contract is a fixed-price with economic price adjustment arrangement. This order is part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle that Boston Scientific holds with the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices, for the delivery of the ELUVIA Drug Eluting Stent. The $5,122.84 fixed-price with economic price adjustment contract has a completion date of December 20, 2024. Boston Scientific, doing business as Boston Scientific, specializes in developing innovative, minimally invasive medical technologies for use in various clinical areas, including...